Natixis Advisors, L.P. Relay Therapeutics, Inc. Transaction History

Natixis Advisors, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $2,132 - $3,701	118 Added 0.7%	16,888 $378,000
Q2 2022 Aug 12, 2022	BUY	$13.31 - $34.88 $3,034 - $7,952	228 Added 1.38%	16,770 $281,000
Q1 2022 May 12, 2022	SELL	$20.26 - $32.36 $1,823 - $2,912	-90 Reduced 0.54%	16,542 $495,000
Q4 2021 Feb 08, 2022	BUY	$26.0 - $37.03 $160,654 - $228,808	6,179 Added 59.11%	16,632 $511,000
Q3 2021 Nov 15, 2021	SELL	$29.75 - $37.99 $261,264 - $333,628	-8,782 Reduced 45.66%	10,453 $330,000
Q1 2021 May 05, 2021	BUY	$32.52 - $61.53 $625,522 - $1.18 Million	19,235 New	19,235 $664,000

203

156M

207K

40K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $588M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.